Vallieres C, Golinelli-Cohen M, Guittet O, Lepoivre M, Huang M, Vernis L
Genes (Basel). 2023; 14(4).
PMID: 37107536
PMC: 10138290.
DOI: 10.3390/genes14040778.
Alshahrani S, Khafagy E, Riadi Y, Al Saqr A, Alfadhel M, Hegazy W
Pharmaceutics. 2022; 14(8).
PMID: 36015271
PMC: 9415822.
DOI: 10.3390/pharmaceutics14081646.
Ansari I, Basak R, Mukhopadhyay A
Pathogens. 2022; 11(5).
PMID: 35631106
PMC: 9143042.
DOI: 10.3390/pathogens11050585.
Tang C, He S, Wang N, Chen L
Ann Transl Med. 2022; 10(8):497.
PMID: 35571385
PMC: 9096369.
DOI: 10.21037/atm-22-1351.
Bernatchez J, Kil Y, Barbosa da Silva E, Thomas D, McCall L, Wendt K
ACS Omega. 2022; 7(9):7675-7682.
PMID: 35284725
PMC: 8908367.
DOI: 10.1021/acsomega.1c06347.
Splenectomy for Visceral Leishmaniasis Out of an Endemic Region: A Case Report and Literature Review.
Lekic N, Tadic B, Djordjevic V, Basaric D, Micev M, Vucelic D
Medicina (Kaunas). 2022; 58(2).
PMID: 35208507
PMC: 8875283.
DOI: 10.3390/medicina58020184.
Rapid Clinical Management of Leishmaniasis in Emergency Department: A Case Report with Clinical Review of Recent Literature.
Piccioni A, Valletta F, Zanza C, Longhitano Y, Torelli E, de Cunzo T
Biology (Basel). 2020; 9(11).
PMID: 33113951
PMC: 7690715.
DOI: 10.3390/biology9110351.
Evaluation of the Pharmacophoric Role of the O-O Bond in Synthetic Antileishmanial Compounds: Comparison between 1,2-Dioxanes and Tetrahydropyrans.
Ortalli M, Varani S, Cimato G, Veronesi R, Quintavalla A, Lombardo M
J Med Chem. 2020; 63(21):13140-13158.
PMID: 33091297
PMC: 8018184.
DOI: 10.1021/acs.jmedchem.0c01589.
Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo.
Coser E, Ferreira B, Branco N, Yamashiro-Kanashiro E, Lindoso J, Coelho A
Int J Parasitol Drugs Drug Resist. 2020; 14:91-98.
PMID: 33011651
PMC: 7548989.
DOI: 10.1016/j.ijpddr.2020.08.001.
Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?.
de Lima U, Vanolli L, Moraes E, Ithamar J, de Azevedo C
PLoS One. 2019; 14(12):e0225875.
PMID: 31805100
PMC: 6894860.
DOI: 10.1371/journal.pone.0225875.
Oral activity of the antimalarial endoperoxide 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) against Leishmania donovani complex.
Kwofie K, Sato K, Sanjoba C, Hino A, Shimogawara R, Amoa-Bosompem M
PLoS Negl Trop Dis. 2019; 13(3):e0007235.
PMID: 30908481
PMC: 6433226.
DOI: 10.1371/journal.pntd.0007235.
Visceral leishmaniasis and HIV coinfection: current perspectives.
Lindoso J, Moreira C, Cunha M, Queiroz I
HIV AIDS (Auckl). 2018; 10:193-201.
PMID: 30410407
PMC: 6197215.
DOI: 10.2147/HIV.S143929.
Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.
Sunyoto T, Potet J, Boelaert M
BMJ Glob Health. 2018; 3(3):e000709.
PMID: 29736277
PMC: 5935166.
DOI: 10.1136/bmjgh-2018-000709.
A brief history of antibiotics and select advances in their synthesis.
Nicolaou K, Rigol S
J Antibiot (Tokyo). 2017; 71(2):153-184.
PMID: 28676714
DOI: 10.1038/ja.2017.62.
Artemisinin and its derivatives in treating protozoan infections beyond malaria.
Loo C, Lam N, Yu D, Su X, Lu F
Pharmacol Res. 2016; 117:192-217.
PMID: 27867026
PMC: 5316320.
DOI: 10.1016/j.phrs.2016.11.012.
Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment.
Georgiadou S, Makaritsis K, Dalekos G
J Transl Int Med. 2016; 3(2):43-50.
PMID: 27847886
PMC: 4936444.
DOI: 10.1515/jtim-2015-0002.
Natural Products: Insights into Leishmaniasis Inflammatory Response.
Rodrigues I, Mazotto A, Cardoso V, Alves R, Amaral A, Silva J
Mediators Inflamm. 2015; 2015:835910.
PMID: 26538837
PMC: 4619978.
DOI: 10.1155/2015/835910.
Renal involvement in leishmaniasis: a review of the literature.
Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz D
NDT Plus. 2015; 4(3):147-52.
PMID: 25984144
PMC: 4421603.
DOI: 10.1093/ndtplus/sfr008.
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease.
Boelaert M, Verdonck K, Menten J, Sunyoto T, van Griensven J, Chappuis F
Cochrane Database Syst Rev. 2014; (6):CD009135.
PMID: 24947503
PMC: 4468926.
DOI: 10.1002/14651858.CD009135.pub2.
Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens.
Salavati R, Moshiri H, Kala S, Najafabadi H
Int J Parasitol Drugs Drug Resist. 2014; 2:36-46.
PMID: 24533263
PMC: 3862403.
DOI: 10.1016/j.ijpddr.2011.10.003.